US Regulator: No Evidence Yet Linking Weight-Loss Drugs to Suicidal Thoughts

This image provided by Novo Nordisk in January 2023 shows packaging for the company's Wegovy drug.

The U.S. Food and Drug Administration said on Thursday its preliminary review did not find evidence that weight-loss drugs such as Novo Nordisk's NOVOb.CO Wegovy were tied to suicidal thoughts and the agency will continue to study the issue.